Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy

Published:2017-10-20 Issue:4 Volume:48 Page:233-243
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Uemura Hayato¹,Uchida Yoshihito¹,Kouyama Jun-ichi¹,Naiki Kayoko¹,Yamaba Shinpei¹,Fuchigami Akira¹,Saito Yoichi¹,Shiokawa Keisuke¹,Fujii Yohei¹,Uchiya Hiroshi¹,Nakazawa Manabu¹,Ando Satsuki¹,Nakao Masamitsu¹,Motoya Daisuke¹,Sugawara Kayoko¹,Inao Mie¹,Imai Yukinori¹,Nakayama Nobuaki¹,Tomiya Tomoaki¹,Mochida Satoshi¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Faculty of Medicine; Saitama Medical University; Saitama Japan

Funder

Ochiai Memorial Foundation

Grant Fostering Young Physician from Saitama Medical University Hospital

Grants-in-Aid of the Ministry of Health, Labour and Welfare, Japan Agency for Medical Research and Development (AMED)

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12980/fullpdf

Reference29 articles.

1. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection;Kumada;Hepatology,2014

2. A novel simple assay system to quantify the percent HCV-RNA levels of NS5A Y93H mutant strains and Y93 wild-type strains relative to the total HCV-RNA levels to determine the indication for antiviral therapy with NS5A inhibitors;Uchida;PLoS One,2014

3. Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing;Uchida;J Gastroenterol,2016

4. Rapid, sensitive, and accurate evaluation of drug resistant mutant (NS5A-Y93H) strain frequency in genotype 1b HCV by invader assay;Yoshimi;PLoS One,2015

5. Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism;Uchida;Hepatol Res,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus;PLOS ONE;2020-11-05

2. Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus;Hepatology Research;2020-04

3. Retreatment of chronic hepatitis C virus genotype-4 patients after non-structural protein 5A inhibitors' failure: efficacy and safety of different regimens;European Journal of Gastroenterology & Hepatology;2020-03

4. Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis;Wellcome Open Research;2019-09-06

5. NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir;Journal of Gastroenterology;2019-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3